Historical record - last NADAC effective date: 5/1/2015
Product Information
UROCIT-K ER 15 MEQ TABLET is a brand product labeled by Mission Pharmacal Company, priced at $3.5507 per EA under NDC 00178061501. Its NADAC has been published 129 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the potassium citrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 meq/1
Manufacturer
Mission Pharmacal CompanyNDC
00178061501
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/1/2015
Active Ingredients
POTASSIUM CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA019071FDA Approved
8/30/1985
TE Code
AB
On Market Since
1/27/2010
Pharmacological Classes
Price Statistics
The NADAC for UROCIT-K ER 15 MEQ TABLET has been published 129 times since Nov 28, 2013, and over the history we have for it it has risen 119.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5507 per EA |
|---|---|
| All-time high | $3.5507 (May 11, 2016) |
| All-time low | $1.6190 (Nov 28, 2013) |
| Median price | $3.3816 |
| Average price | $3.0992 |
| Largest weekly change | +40.0% (Dec 25, 2013) |
| Weeks tracked | 129 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+119.3%
Last surveyed May 11, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UROCIT-K ER 15 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UROCIT-K ER 15 MEQ TABLET, manufactured by Mission Pharmacal Company, is $3.5507 per EA (NDC 00178061501), effective May 11, 2016.
How has the price of UROCIT-K ER 15 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for UROCIT-K ER 15 MEQ TABLET has risen 119.3%. It has been tracked across 129 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for UROCIT-K ER 15 MEQ TABLET?
Since Nov 28, 2013, the NADAC for UROCIT-K ER 15 MEQ TABLET has ranged from a low of $1.6190 (Nov 28, 2013) to a high of $3.5507 (May 11, 2016), with a median of $3.3816 per EA.
Are there cheaper alternatives to UROCIT-K ER 15 MEQ TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CITRATE ER 15 MEQ TB, is $0.1804 per EA — about 95% below UROCIT-K ER 15 MEQ TABLET.
Who manufactures UROCIT-K ER 15 MEQ TABLET?
UROCIT-K ER 15 MEQ TABLET (NDC 00178061501) is labeled by Mission Pharmacal Company, and CMS classifies it as a brand product.